Global and United States Home/Self Testing Market Report & Forecast 2023-2029

Report ID: ARS1420 | Category: Healthcare | Pages: 114 | Format: PDF | Published Date: August 16,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$4350.00 Multi User-$6300.00

Report Description
View Table of Contents

Report Summary

The research time span covered by the report is from 2018 to 2029; it provides an overview of the Global Home/Self Testing Market and also provides a deeper in-depth segmentation of the market by regions, product type and downstream industries.

The global Home/Self Testing market size in 2022 is XX million US dollars, and it is expected to be 39180.0 million US dollars by 2029, with a compound annual growth rate of 8.70% expected in 2023-2029.

MARKET COMPETITIVE LANDSCAPE:
The main players in the Home/Self Testing market include PRIMA Lab SA (Switzerland), bioLytical Laboratories Inc. (Canada), OraSure Technologies, Inc. (U.S.), Nectar Lifesciences Ltd. (India), and Piramal Enterprises Ltd. (India). The share of the top 3 players in the Home/Self Testing market is XX%.

REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Home/Self Testing market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:
The report segments the market by Type and Application. Diagnostic Kits accounted for XX% of Home/Self Testing market in 2022. Diagnostic Device share of XX%.
Cholesterol and Triglycerides Tests accounted for XX% of the Home/Self Testing market in 2022. Diabetes and Glucose Tests accounts for XX%.

For competitive landscape, prominent players with considerable market shares are comprehensively analyzed in this report. With information regarding the concentration ratio and detailed data reflecting the market performance of each player shared, the readers can acquire a holistic view of the competitive situation and a better understanding of their competitors.

As the COVID-19 takes over the world, we are continuously tracking the changes in the markets. We analyzed the impact of the pandemic in detail, along with other key factors, such as macro-economy, regional conflicts, industry related news and policies. Meanwhile, market investment scenario, technology status and developments, supply chain challenges, among other essential research elements are all covered.

Key Factors Considered:
COVID-19
The report describes the market scenario during and post the pandemic in the vision of upstream, major market participants, downstream major customers, etc. Other aspects, such as changes in consumer behavior, demand, transport capacity, trade flow under COVID-19, have also been taken into consideration during the process of the research.

Regional Conflict / Russia-Ukraine War
The report also presents the impact of regional conflict on this market in an effort to aid the readers to understand how the market has been adversely influenced and how it's going to evolve in the years to come.

Challenges & Opportunities
Factors that may help create opportunities and boost profits for market players, as well as challenges that may restrain or even pose a threat to the development of the players, are revealed in the report, which can shed a light on strategic decisions and implementation.

The life sciences industry grows and continues to advance, driving innovation and improving healthcare outcomes for individuals around the world.

Artificial Intelligence (AI) and Machine Learning (ML): AI and ML technologies are increasingly being employed in life sciences research and development. They aid in drug discovery, optimizing clinical trials, analyzing vast amounts of biological data, and identifying patterns that can lead to breakthroughs in understanding diseases and developing new therapies.

Digital Health Technologies: Digital health technologies have seen rapid growth, especially in areas like telemedicine, wearable devices, and mobile health applications. These technologies enable remote patient monitoring, facilitate better healthcare access, and empower individuals to manage their health more effectively.

Wearable Devices and Remote Monitoring: Wearable devices, such as smartwatches and fitness trackers, have become more sophisticated, enabling continuous monitoring of vital signs and health parameters. These devices offer opportunities for early detection of health issues and improved management of chronic conditions.

Highlights-Regions

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Latin America
Brazil
Argentina
Mexico
MEA
Saudi Arabia
UAE
Turkey

Player list
PRIMA Lab SA (Switzerland)
bioLytical Laboratories Inc. (Canada)
OraSure Technologies, Inc. (U.S.)
Nectar Lifesciences Ltd. (India)
Piramal Enterprises Ltd. (India)
Cardinal Health (U.S.)
Johnson & Johnson Services, Inc (U.S.)
B. Braun Melsungen AG (Germany)
BD (U.S.)
Abbott (U.S.)
F. Hoffmann-La Roche Ltd. (Switzerland)
Alere Inc. (U.S.)
Beckman Coulter, Inc. (U.S.)
Siemens Medical Solutions USA Inc. (U.S.)
Bio-Rad Laboratories, Inc. (U.S.)
bioMérieux (France)

Types list
Diagnostic Kits
Diagnostic Device
Diagnostic Strips

Application list
Cholesterol and Triglycerides Tests
Diabetes and Glucose Tests
Others

Table of Content

1 Study Coverage
1.1 Home/Self Testing Product Introduction
1.2 Global Home/Self Testing Outlook 2018 VS 2023 VS 2029
1.3 United States Home/Self Testing Outlook 2018 VS 2023 VS 2029
1.4 Home/Self Testing Market Size, United States VS Global, 2018-2029
1.4.1 The Market Share of United States Home/Self Testing in Global, 2018-2029
1.4.2 The Growth Rate of Home/Self Testing Market Size, United States VS Global, 2018 VS 2023 VS 2029
1.5 Home/Self Testing Market Dynamics
1.5.1 Home/Self Testing Market Trends
1.5.2 Home/Self Testing Market Drivers
1.5.3 Home/Self Testing Market Challenges
1.5.4 Home/Self Testing Market Restraints
1.6 Study Objectives
1.7 Years Considered
1.8 Coronavirus Disease (COVID-19) Impact on Global
2 Global Home/Self Testing Competitor Landscape by Company
2.1 Global Home/Self Testing Market Size by Company
2.1.1 Top Global Home/Self Testing Player Ranked by Revenue (2023)
2.1.2 Global Home/Self Testing Revenue by Player (2018-2023)
2.2 Global Home/Self Testing Concentration Ratio (CR)
2.2.1 Home/Self Testing Market Concentration Ratio (CR) (2018-2023)
2.2.2 Global Top 3 and Top 6 Largest Players of Home/Self Testing in 2023
2.3 Global Home/Self Testing Business Distribution, Business Type
2.3.1 Global Home/Self Testing Players, Headquarters and Distribution
2.3.2 Players Home/Self Testing Business Type
2.3.3 Date of International Players Enter into Home/Self Testing Market
2.4 Players Mergers & Acquisitions, Expansion Plans
2.5 United States Home/Self Testing Market Size by Company
2.5.1 Top United States Home/Self Testing Player s Ranked by Revenue (2023)
2.5.2 United States Home/Self Testing Revenue by Player (2018-2023)
3 Home/Self Testing Market Segment by Type
3.1 Home/Self Testing Market Segment by Type
3.2 Global Home/Self Testing Market Size by Type
3.3 United States Home/Self Testing Market Size by Type
4 Home/Self Testing by Market Segment Application
4.1 Home/Self Testing Market Segment by Application
4.2 Global Home/Self Testing Market Size by Application
4.3 United States Home/Self Testing Market Size by Application
5 Global Home/Self Testing Market Size by Region
5.1 Global Home/Self Testing Market Size by Region: 2018 VS 2023 VS 2029
5.2 Global Home/Self Testing Market Size in Value by Region (2018-2029)
5.2.1 Global Home/Self Testing Revenue by Region: 2018-2023
5.2.2 Global Home/Self Testing Revenue by Region: 2023-2029
6 Segment in Regional Level & Country Level
6.1 North America
6.1.1 North America Home/Self Testing Market Size YoY Growth 2018-2029
6.1.2 North America Home/Self Testing Market Facts & Figures by Country (2018-2029)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia Pacific
6.2.1 Asia Pacific Home/Self Testing Market Size YoY Growth 2018-2029
6.2.2 Asia Pacific Home/Self Testing Market Facts & Figures by Country (2018-2029)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Southeast Asia
6.3 Europe
6.3.1 Europe Home/Self Testing Market Size YoY Growth 2018-2029
6.3.2 Europe Home/Self Testing Market Facts & Figures by Country (2018-2029)
6.3.3 Germany
6.3.4 France
6.3.5 UK
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Home/Self Testing Market Size YoY Growth 2018-2029
6.4.2 Latin America Home/Self Testing Market Facts & Figures by Country (2018-2029)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Home/Self Testing Market Size YoY Growth 2018-2029
6.5.2 Middle East and Africa Home/Self Testing Market Facts & Figures by Country (2018-2029)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1  PRIMA Lab SA (Switzerland)
7.1.1 Company Details
7.1.2 Description and Business Overview
7.1.3 Home/Self Testing Introduction
7.1.4 PRIMA Lab SA (Switzerland) Home/Self Testing Revenue, Gross, and Gross Margin (2018-2023)
7.1.5 PRIMA Lab SA (Switzerland) Recent Development
7.2  bioLytical Laboratories Inc. (Canada)
7.2.1 Company Details
7.2.2 Description and Business Overview
7.2.3 Home/Self Testing Introduction
7.2.4 bioLytical Laboratories Inc. (Canada) Home/Self Testing Revenue, Gross, and Gross Margin (2018-2023)
7.2.5 bioLytical Laboratories Inc. (Canada) Recent Development
7.3  OraSure Technologies, Inc. (U.S.)
7.3.1 Company Details
7.3.2 Description and Business Overview
7.3.3 Home/Self Testing Introduction
7.3.4 OraSure Technologies, Inc. (U.S.) Home/Self Testing Revenue, Gross, and Gross Margin (2018-2023)
7.3.5 OraSure Technologies, Inc. (U.S.) Recent Development
7.4  Nectar Lifesciences Ltd. (India)
7.4.1 Company Details
7.4.2 Description and Business Overview
7.4.3 Home/Self Testing Introduction
7.4.4 Nectar Lifesciences Ltd. (India) Home/Self Testing Revenue, Gross, and Gross Margin (2018-2023)
7.4.5 Nectar Lifesciences Ltd. (India) Recent Development
7.5  Piramal Enterprises Ltd. (India)
7.5.1 Company Details
7.5.2 Description and Business Overview
7.5.3 Home/Self Testing Introduction
7.5.4 Piramal Enterprises Ltd. (India) Home/Self Testing Revenue, Gross, and Gross Margin (2018-2023)
7.5.5 Piramal Enterprises Ltd. (India) Recent Development
7.6  Cardinal Health (U.S.)
7.6.1 Company Details
7.6.2 Description and Business Overview
7.6.3 Home/Self Testing Introduction
7.6.4 Cardinal Health (U.S.) Home/Self Testing Revenue, Gross, and Gross Margin (2018-2023)
7.6.5 Cardinal Health (U.S.) Recent Development
7.7  Johnson & Johnson Services, Inc (U.S.)
7.7.1 Company Details
7.7.2 Description and Business Overview
7.7.3 Home/Self Testing Introduction
7.7.4 Johnson & Johnson Services, Inc (U.S.) Home/Self Testing Revenue, Gross, and Gross Margin (2018-2023)
7.7.5 Johnson & Johnson Services, Inc (U.S.) Recent Development
7.8  B. Braun Melsungen AG (Germany)
7.8.1 Company Details
7.8.2 Description and Business Overview
7.8.3 Home/Self Testing Introduction
7.8.4 B. Braun Melsungen AG (Germany) Home/Self Testing Revenue, Gross, and Gross Margin (2018-2023)
7.8.5 B. Braun Melsungen AG (Germany) Recent Development
7.9  BD (U.S.)
7.9.1 Company Details
7.9.2 Description and Business Overview
7.9.3 Home/Self Testing Introduction
7.9.4 BD (U.S.) Home/Self Testing Revenue, Gross, and Gross Margin (2018-2023)
7.9.5 BD (U.S.) Recent Development
7.10  Abbott (U.S.)
7.10.1 Company Details
7.10.2 Description and Business Overview
7.10.3 Home/Self Testing Introduction
7.10.4 Abbott (U.S.) Home/Self Testing Revenue, Gross, and Gross Margin (2018-2023)
7.10.5 Abbott (U.S.) Recent Development
7.11   F. Hoffmann-La Roche Ltd. (Switzerland)
7.11.1 Company Details
7.11.2 Description and Business Overview
7.11.3 Home/Self Testing Introduction
7.11.4  F. Hoffmann-La Roche Ltd. (Switzerland) Home/Self Testing Revenue, Gross, and Gross Margin (2018-2023)
7.11.5  F. Hoffmann-La Roche Ltd. (Switzerland) Recent Development
7.12  Alere Inc. (U.S.)
7.12.1 Company Details
7.12.2 Description and Business Overview
7.12.3 Home/Self Testing Introduction
7.12.4 Alere Inc. (U.S.) Home/Self Testing Revenue, Gross, and Gross Margin (2018-2023)
7.12.5 Alere Inc. (U.S.) Recent Development
7.13   Beckman Coulter, Inc. (U.S.)
7.13.1 Company Details
7.13.2 Description and Business Overview
7.13.3 Home/Self Testing Introduction
7.13.4  Beckman Coulter, Inc. (U.S.) Home/Self Testing Revenue, Gross, and Gross Margin (2018-2023)
7.13.5  Beckman Coulter, Inc. (U.S.) Recent Development
7.14   Siemens Medical Solutions USA Inc. (U.S.)
7.14.1 Company Details
7.14.2 Description and Business Overview
7.14.3 Home/Self Testing Introduction
7.14.4  Siemens Medical Solutions USA Inc. (U.S.) Home/Self Testing Revenue, Gross, and Gross Margin (2018-2023)
7.14.5  Siemens Medical Solutions USA Inc. (U.S.) Recent Development
7.15   Bio-Rad Laboratories, Inc. (U.S.)
7.15.1 Company Details
7.15.2 Description and Business Overview
7.15.3 Home/Self Testing Introduction
7.15.4  Bio-Rad Laboratories, Inc. (U.S.) Home/Self Testing Revenue, Gross, and Gross Margin (2018-2023)
7.15.5  Bio-Rad Laboratories, Inc. (U.S.) Recent Development
7.16   bioMérieux (France)
7.16.1 Company Details
7.16.2 Description and Business Overview
7.16.3 Home/Self Testing Introduction
7.16.4  bioMérieux (France) Home/Self Testing Revenue, Gross, and Gross Margin (2018-2023)
7.16.5  bioMérieux (France) Recent Development
8 Value Chain and Sales Channels Analysis
8.1 Home/Self Testing Value Chain Analysis
8.2 Home/Self Testing Customers
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology
10.1.1 Research Process
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Legal Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global and United States Home/Self Testing Market Report & Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?